WHO ICTRP trial
Study of ifenprodil effects on patients with methamphetamine dependence and…
JPRN-UMIN000030849 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000030849 |
|---|---|
| Public title | Study of ifenprodil effects on patients with methamphetamine dependence and development of fMRI biomarkers for methamphetamine dependence |
| Scientific title | Study of ifenprodil effects on patients with methamphetamine dependence and development of fMRI biomarkers for methamphetamine dependence - Study of ifenprodil in methamphetamine dependence |
| Primary sponsor | National Center of Neurology and Psychiatry, National Center Hospital |
| Secondary sponsors | Tokyo Metropolitan Institute of Medical Science, National Center of Neurology and Psychiatry (Integrative Brain Imaging Center), Kyoto University, Advanced Telecommunications Research Institute… |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Stimulant Use Disorder (amphetamine-type substance) |
| Interventions | Ifenprodil (120 mg/day, 84 days) Ifenprodil (60 mg/day, 84 days) Placebo (84 days) |
| Registration date | Jan 17, 2018 |
| Target size | 80 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: